Executive Summary
The 30 new federal contracts totaling $84.8B are dominated by massive DOE management contracts for nuclear security and renewable labs ($70B+ across top 4), mostly to private/non-profits with limited public exposure, signaling sustained U.S. nuclear/renewable R&D priority. NASA awards ($6.9B) affirm space investments, bullish for Boeing ($2.2B SLS) and sector peers amid Artemis/SLS momentum. Public firms like Booz Allen Hamilton ($990M across VA/GSA), Lockheed Martin ($479M FAA), and General Dynamics ($449M SEC) capture high-value IT/ops wins, providing revenue visibility despite common funding/execution gaps.
Investment Signals(4)
- DOE nuclear/renewable lab M&O contracts exceed $70B(HIGH)▲
Enormous awards to entities like Consolidated Nuclear Security ($32B) and Alliance for Sustainable Energy ($10B) highlight long-term funding stability for nuclear security and clean energy R&D, though private recipients limit direct equity upside.
- NASA space infrastructure wins total $6.9B(HIGH)▲
Contracts for SLS stages (Boeing $2.2B), human landers (Blue Origin $1.7B), and Mobile Launcher (Bechtel $1.5B) validate Artemis/SLS priorities, boosting space primes and sector sentiment.
- Public contractors secure $3B+ in civ IT/health wins(MEDIUM)▲
Booz Allen Hamilton ($990M VA/GSA/CDC), Lockheed ($479M FAA), GD ($449M SEC) capture large delivery orders in health IT, data modernization, and infrastructure.
- $0 base/options across 90%+ of awards flags funding uncertainty(HIGH)▲
Total values average $2.8B but $0 base/options in most (e.g., top DOE/NASA) indicate ceiling-funded structures reliant on incremental obligations.
Risk Flags(3)
- Execution[HIGH RISK]▼
Technical complexity in nuclear ops, SLS production, human landers, and D&D cleanup prevalent across top awards
- Regulatory[CRITICAL RISK]▼
DOE/NNSA oversight and compliance hurdles in nuclear/weapons sites (e.g., Y-12, Pantex, NNSS)
- Market[MEDIUM RISK]▼
Private/non-profit recipients (80% of value) mute public market upside despite scale
Opportunities(3)
- ◆
Follow-on task orders/extensions in DOE labs (NREL, LBNL, PPPL) and NASA SLS/Artemis programs
- ◆
Expansion in fed health IT/data mod (VA $590M/$181M, CDC $400M, Medicare $378M)
- ◆
Border/aviation security ramps (Anduril towers $363M, Northrop P-3 $321M, Gulfstream aircraft $172M)
Sector Themes(3)
- ◆
Top 6 awards ($65B+) to labs/sites underscore multi-decade commitments despite private ops.
- ◆
$6.9B across 10 contracts signals accelerating space infra/human exploration spend.
- ◆
15+ awards ($5B+) in VA, GSA, CDC, IRS highlight steady civilian demand.
Watch List(4)
- 👁
{"entity"=>"Boeing (SLS $2.2B)", "reason"=>"Largest public award; core to NASA flagship but execution history mixed", "trigger"=>"Artemis launch delays or follow-on funding"}
- 👁
{"entity"=>"Booz Allen Hamilton ($990M total)", "reason"=>"Multiple civ health/IT wins amplify revenue visibility", "trigger"=>"Q4 earnings guidance uplift"}
- 👁
{"entity"=>"DOE Lab Renewals (NREL, LBNL)", "reason"=>"$29B combined; private but signal recompete scale for sector", "trigger"=>"2026 solicitation releases"}
- 👁
{"entity"=>"Funding Obligations", "reason"=>"$0 base/options in 28/30 contracts risks drawdown shortfalls", "trigger"=>"quarterly obligation reports"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC